MTOR and Glucose intolerance: found that structural and functional changes in the microbiota drive the development of glucose intolerance in rats, raising serum BCAA levels, and suggested that BCAA-induced IR may be related to the mammalian target of rapamycin (mTOR) signaling pathway (Yu et al., 2024).